News
06/2014 STC Biologics presents at 5th Annual Summit on Biosimilars ACI Conference in New York City

03/2014  STC Biologics presents on new modeling approaches to biosimilar development at SMI Biosimilar and Biobetter 2014 Conference in New Jersey

11/08/2013 STC Biologics publishes a whitepaper on Rethinking Biosimilar Development ( http://www.chemanager-online.com/en/topics/pharma-biotech-processing/rethinking-biosimilar-development) 

10/15/2013  STC Biologics, Inc presents at IRR Business of Biosimilars Examining The approval Path for an antibody and Lesson of Liasing with EMEA

04/29/2013 STC Biologics, Inc presents at PEGS in Boston on lessons learn from biosimilar development

04/20/2013  STC Biologics exhibits at BIO in Chicago and meets with pharmaceutical companies around the world to discuss licensing opportunities for STC101, a biosimilar antibody for treatment of cancer. STC also launches its biosolutions group to help partner companies to expedite their development

11/27/2012  STC Biologics presents at World Generic Medicines Congress of Americas 2011 in Washington DC

10/10/2012  STC Biologics, Inc Receives $2.5M SBIR Phase II Contract from the National Cancer Institute to continue Biosimilar Development
05/15/2012 STC Biologics to attend BIO in Boston

03/30/2012 STC Biologics, Inc presents at PEGS on biosimilar pre-conference workshop

03/09/2012 STC Presents at BPQC Summit at University of Lowell

03/05/2012 STC Biologic,Inc. presents at CBI’s 7th Summit on Biosimilars and Follow-On Biologics in Washington D.C
10/05/2011 STC Biologics presents at the at the “Partnership Opportunities in Drug Delivery (PODD)” Conference being held at the Omni Parker Hotel in Boston, MA
08/25/2011 STC Biologics to present at Business of Biosimilars and Biobetters in Boston, September 19-21
08/25/2011 STC Biologics to present at World Generic Medicines Congress of Americas 2011 in Washington DC, November 15-17, 2011
06/28/2011 STC Biologics, Inc. to present at IIR's Fist Annual Business of Biosimilars conference in Boston, Sep 2009
06/27/2011 STC Biologics, Inc. attends BIO in Washington, DC
06/08/2011 STC Biologics, Inc. to Co-Chair IIR's 2nd Annual Business of Biosimilars conference, Sep-20-2010 through Sep-22-2010 in Boston ,MA
05/25/2011 STC Biologics, Inc. to present at the ACI
09/24/2010 STC Biologics, Inc. to present at World Generic Medicines Congress Americas 2010, Nov-16-2010 at the Westin Grand, Washington DC.
07/30/2010 STC Biologics, Inc. is awarded a contract from National Cancer Institute to develop its first monoclonal antibody biosimilar
http://www.chemanager-online.com/en/topics/pharma-biotech-processing/rethinking-biosimilar-developmenthttp://www.chemanager-online.com/en/topics/pharma-biotech-processing/rethinking-biosimilar-developmenthttp://www.biospace.com/News/stc-biologics-inc-receives-2-5-million-sbir-phase/275671http://www.biospace.com/News/stc-biologics-inc-receives-2-5-million-sbir-phase/275671shapeimage_2_link_0shapeimage_2_link_1shapeimage_2_link_2shapeimage_2_link_3
Accelerating biologics development
Services to expedite your drug development

Express your protein of interest in mammalian cells
Measure the activity of your compounds in various cancer cell line (ie proliferation, growth in soft agar, angiogenesis)
Profile your compounds in cancer cells line
Develop a new process for biologic production
Analyze your protein for purity and PTMs
Measure ADCC response 
BioSolutions.html